Post-IPO Equity - Arbutus Biopharma - Oct 2, 2017 Funding Round Profile - Cointime

Bitcoin $98,631.13 +0.48%
Ethereum $3,467.10 +4.76%
BNB $671.18 +8.02%
Optimism $2.30 +5.12%
Arbitrum $0.87 +9.31%
Solana $260.08 +1.24%
Polygon $0.57 +25.01%
Cosmos $8.15 +16.83%
Avalanche $42.85 +11.84%

Bitcoin $98,631.13 +0.48%
Ethereum $3,467.10 +4.76%
BNB $671.18 +8.02%
Optimism $2.30 +5.12%
Arbitrum $0.87 +9.31%
Solana $260.08 +1.24%
Polygon $0.57 +25.01%
Cosmos $8.15 +16.83%
Avalanche $42.85 +11.84%

Arbutus Biopharma

company

Funding Round

Post-IPO Equity

Money Raised

$ 116.40M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Roivant Sciences	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 13, 2010	Grant	$ 2.40M	National Institutes of Health	Detail